NexMR developed a proprietary NMR-based high throughput drug discovery engine.
Thanks to its sensitivity enhanced NMR core technology our platform screens fragment libraries at unprecedented rate.
In addition, we can assess the hit affinities and determine the target-ligand structures. The fully characterized hits complement perfectly other assays to provide an atomic-scale structure-activity relationship.
NMhare is versatile and can unravel challenging targets by skipping tedious assay development.
- 5 seconds for 1 measurement: high throughput
- Low micromolar samples: less material
- No assay development: versatility
- Implementable on any spectrometer: accessible